Tomasz Beer, MD Speaks On Xtandi, Erleada, & Nubeqa | Excerpt from the 2019 PCRI Conference

Medical oncologist, Tomasz Beer, MD, speaks at the 2019 Prostate Cancer Patient Conference on the factors he considers when deciding to prescribe a patient either Xtandi (enzalutamide), Erleada (apalutamide), or Nubeqa (darolutamide). Tomasz Beer, MD, FACP, is the Grover C. Bagby Endowed Chair for Prostate Cancer Research, Professor of Medicine, and Deputy Director of OHSU Knight Cancer Institute, an NCI-designated Cancer Center. Dr. Beer received his medical degree from John Hopkins School of Medicine in 1991 and completed his internship and residency in internal medicine and fellowship in Hematology and Medical Oncology at Oregon Health & Science University. Dr. Beer has been the leader of the Prostate Cancer Research Program at OHSU for more than a decade. He is an internationally renowned medical oncologist known for leading a number of clinical trials for prostate cancer prevention and treatment. He is currently a group leader on Stand Up To Cancer (SU2C) prostate cancer dream team. Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org To learn more about prostate cancer visit http://www.pcri.org To download the free Staging Guide visit http://www.pcri.org/prostate-cancer-s... Who we are: The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors. The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs. #ProstateCancer #Prostate #MarkScholzMD